Filtros de búsqueda

Lista de obras de

18F-Fluorodeoxyglucose Uptake in Hepatocellular Carcinoma as a Useful Predictor of an Extremely Rapid Response to Lenvatinib

artículo científico publicado en 2019

A Patient with HCV Infection and a Sustained Virological Response to Direct-acting Antiviral Treatment who Developed Inclusion Body Myositis.

artículo científico publicado en 2018

A Pilot Study of Thymosin .ALPHA.1 Therapy for Chronic Hepatitis B Patients ⬇️

artículo científico publicado el 1 de octubre de 2003

A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients.

artículo científico publicado en 2006

A matched case-controlled study of 48 and 72 weeks of peginterferon plus ribavirin combination therapy in patients infected with HCV genotype 1b in Japan: amino acid substitutions in HCV core region as predictor of sustained virological response.

artículo científico publicado en 2009

A randomized trial of daclatasvir with peginterferon alfa-2b and ribavirin for HCV genotype 1 infection

artículo científico publicado en 2014

Adefovir dipivoxil for treatment of breakthrough hepatitis caused by lamivudine-resistant mutants of hepatitis B virus.

artículo científico publicado en 2004

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C.

artículo científico publicado en 2004

Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer.

artículo científico publicado en 2010

Advantage of liver stiffness measurement before and after direct-acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C

scientific article published on 12 January 2020

Amino Acid Substitutions in the Hepatitis C Virus Core Region Predict Hepatocarcinogenesis Following Eradication of HCV RNA by All-Oral Direct-Acting Antiviral Regimens.

artículo científico publicado en 2018

Amino acid substitution in HCV core region and genetic variation near the IL28B gene affect viral dynamics during telaprevir, peginterferon and ribavirin treatment

artículo científico publicado en 2012

Amino acid substitution in HCV core/NS5A region and genetic variation near IL28B gene affect treatment efficacy to interferon plus ribavirin combination therapy

artículo científico publicado en 2011

Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin.

artículo científico publicado en 2010

Amino acid substitutions in hepatitis C virus core region predict hepatocarcinogenesis following eradication of HCV RNA by antiviral therapy.

artículo científico publicado en 2011

Amino acid substitutions in the hepatitis C Virus core region and lipid metabolism are associated with hepatocarcinogenesis in nonresponders to interferon plus ribavirin combination therapy.

artículo científico publicado en 2012

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

artículo científico publicado en 2007

Amino acid substitutions in the hepatitis C virus core region of genotype 1b affect very early viral dynamics during treatment with telaprevir, peginterferon, and ribavirin.

artículo científico publicado en 2010

Amino acid substitutions in the hepatitis C virus core region of genotype 1b are the important predictor of severe insulin resistance in patients without cirrhosis and diabetes mellitus.

artículo científico publicado en 2009

An open pilot study exploring the efficacy of fluvastatin, pegylated interferon and ribavirin in patients with hepatitis C virus genotype 1b in high viral loads.

artículo científico publicado en 2009

Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma.

artículo científico publicado en 2016

Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center

artículo científico publicado en 2006

Antitumor efficacy of transcatheter arterial chemoembolization with warmed miriplatin in hepatocellular carcinoma

artículo científico publicado en 2013

Association of HLA-DR14 with the treatment response in Japanese patients with autoimmune hepatitis

artículo científico publicado en 2010

Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy.

artículo científico publicado en 2012

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 1b high viral load and non-virological response to interferon-ribavirin combination therapy.

artículo científico publicado en 2005

Association of amino acid substitution pattern in core protein of hepatitis C virus genotype 2a high viral load and virological response to interferon-ribavirin combination therapy.

artículo científico publicado en 2009

Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy.

artículo científico publicado en 2003

Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.

artículo científico publicado en 2012

Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinoma

artículo científico publicado en 2016

Benefit of lamivudine therapy and factors associated with clinical outcome in spontaneous severe acute exacerbation of chronic hepatitis B virus infection

artículo científico publicado en 2004

Biphasic skin reactions during telaprevir-based therapy of Japanese patients infected with hepatitis C virus

artículo científico publicado en 2014

Change of hepatitis B virus genotypes in acute and chronic infections in Japan

artículo científico publicado en 2008

Changes in viral loads of lamivudine-resistant mutants during entecavir therapy

artículo científico publicado en 2007

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

artículo científico publicado en 2012

Cholangiolocellular Carcinoma in a Young Patient Who Showed Sustained Virological Response after Treatment for Hepatitis C Virus Infection

artículo científico publicado en 2017

Circulating MicroRNA-122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD

artículo científico publicado en 2019

Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance

scientific article published on 10 July 2018

Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study

artículo científico publicado en 2012

Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome

artículo científico publicado en 2004

Clinical and virological characteristics of untreated patients with chronic hepatitis C who develop serum alanine aminotransferase flare-up

artículo científico publicado en 2005

Clinical and virological effects of long-term (over 5 years) lamivudine therapy

artículo científico publicado en 2010

Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants

artículo científico publicado en 2006

Clinical characteristics of patients infected with hepatitis B virus genotypes A, B, and C.

artículo científico publicado en 2002

Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan

artículo científico publicado en 2013

Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers ⬇️

artículo científico publicado el 10 de octubre de 2012

Clinical features of hepatitis B virus genotype A in Japanese patients.

artículo científico publicado en 2003

Clinical significance of hepatectomy for primary biliary cirrhosis patients with hepatocellular carcinoma: Report of a single center case series and review of the published work

artículo científico

Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients

artículo científico publicado en 2008

Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period.

artículo científico publicado en 2007

Combination therapy of peginterferon and ribavirin for chronic hepatitis C patients with genotype 1b and low-virus load

artículo científico publicado en 2009

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B

scientific article published on 01 September 2007

Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis

artículo científico publicado en 2012

Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis. A nested case-control study using 96 untreated patients

artículo científico publicado en 2003

Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

artículo científico publicado en 2018

Correlation between hepatitis B virus surface antigen level and alpha-fetoprotein in patients free of hepatocellular carcinoma or severe hepatitis

artículo científico publicado en 2013

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

artículo científico publicado en 2009

Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter

artículo científico publicado en 2005

Current Status of Hepatocellular Carcinoma Treatment in Japan

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

artículo científico publicado en 2014

Detection of TERT promoter mutation in serum cell-free DNA using wild-type blocking PCR combined with Sanger sequencing in hepatocellular carcinoma

artículo científico publicado en 2020

Determinants of response to triple therapy of telaprevir, peginterferon, and ribavirin in previous non-responders infected with HCV genotype 1.

artículo científico publicado en 2012

Determinants of serum ALT normalization after phlebotomy in patients with chronic hepatitis C infection

artículo científico publicado en 2005

Determinants of the clinical outcome of patients with severe acute exacerbation of chronic hepatitis B virus infection.

artículo científico publicado en 2012

Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants.

artículo científico publicado en 2009

Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels.

artículo científico publicado en 2009

Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy.

artículo científico publicado en 2011

Diabetes enhances hepatocarcinogenesis in noncirrhotic, interferon-treated hepatitis C patients

artículo científico publicado en 2010

Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report.

artículo científico publicado en 2007

Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis

scientific article published on 17 August 2008

Diagnosis and Resection Treatment of Triplet Hepatocellular Carcinomas with a non-B non-C Background in a Middle Aged Man over a Period of 6-years

artículo científico publicado en 2020

Difference in malignancies of chronic liver disease due to non-alcoholic fatty liver disease or hepatitis C in Japanese elderly patients

artículo científico publicado en 2011

Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.

artículo científico publicado en 2017

Discrimination of fibrotic staging of chronic hepatitis C using multiple fibrotic markers

artículo científico publicado en 2013

Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure-Response Analyses

artículo científico publicado en 2017

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

artículo científico publicado en 2012

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders

artículo científico publicado en 2012

Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis

artículo científico publicado en 2006

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

artículo científico publicado en 2005

Effect of acute self-limited hepatitis C virus (HCV) superinfection on hepatitis B virus (HBV)-related cirrhosis. Virological features of HBV-HCV dual infection

artículo científico publicado en 2004

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

artículo científico publicado en 2013

Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients

artículo científico publicado en 2014

Effectiveness of Particle Radiotherapy in Various Stages of Hepatocellular Carcinoma: A Pilot Study

artículo científico publicado en 2018

Effectiveness of combination therapy of splenectomy and long-term interferon in patients with hepatitis C virus-related cirrhosis and thrombocytopenia

artículo científico publicado en 2009

Effects of Alcohol Consumption on Hepatocarcinogenesis in Japanese Patients With Fatty Liver Disease

artículo científico publicado en 2015

Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies.

artículo científico publicado en 2017

Effects of alcohol consumption on multiple hepatocarcinogenesis in patients with fatty liver disease

scientific article published on 16 September 2020

Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib

scientific article published on 19 September 2020

Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2.

artículo científico publicado en 2007

Efficacy and anticarcinogenic activity of ribavirin combination therapy for hepatitis C virus-related compensated cirrhosis

artículo científico publicado en 2012

Efficacy and safety in sitagliptin therapy for diabetes complicated by chronic liver disease caused by hepatitis C virus.

artículo científico publicado en 2011

Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver disease.

artículo científico publicado en 2013

Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 1b and high virus load

artículo científico publicado en 2010

Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients with genotype 2 and high virus load

artículo científico publicado en 2010

Efficacy and safety of combination therapy of natural human interferon beta and ribavirin in chronic hepatitis C patients.

artículo científico publicado en 2011

Efficacy and safety of elbasvir plus grazoprevir combination therapy in Japanese patients infected with hepatitis C virus genotype 1b

artículo científico publicado en 2018

Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection

artículo científico publicado en 2017

Efficacy in patients with dose reduction in combination therapy of peginterferon and ribavirin for chronic hepatitis C.

artículo científico publicado en 2008

Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan.

artículo científico publicado en 2004

Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?

artículo científico publicado en 2009

Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection.

artículo científico publicado en 2006

Efficacy of interferon monotherapy to 394 consecutive naive cases infected with hepatitis C virus genotype 2a in Japan: therapy efficacy as consequence of tripartite interaction of viral, host and interferon treatment-related factors

artículo científico publicado en 2002

Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy

artículo científico publicado en 2004

Efficacy of interferon therapy in elderly patients with chronic hepatitis C.

artículo científico publicado en 2006

Efficacy of lamivudine therapy and factors associated with emergence of resistance in chronic hepatitis B virus infection in Japan.

artículo científico publicado en 2003

Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection

scientific article published on 25 May 2007

Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis

artículo científico publicado en 2004

Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogs

artículo científico publicado en 2016

Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy

artículo científico publicado en 2008

Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin

artículo científico publicado en 2008

Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load

artículo científico publicado en 2003

Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral load

artículo científico publicado en 2012

Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 2 and high virus load.

artículo científico publicado en 2012

Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients.

artículo científico publicado en 2010

Emergence of telaprevir-resistant variants detected by ultra-deep sequencing after triple therapy in patients infected with HCV genotype 1.

artículo científico publicado en 2013

Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load.

artículo científico publicado en 2007

Evolution of simeprevir-resistant variants in virological non-responders infected with HCV genotype 1b.

artículo científico publicado en 2015

Evolution of simeprevir-resistant variants over time by ultra-deep sequencing in HCV genotype 1b.

artículo científico publicado en 2014

Exploratory study on telaprevir given every 8 h at 500 mg or 750 mg with peginterferon-alpha-2b and ribavirin in hepatitis C patients.

artículo científico publicado en 2012

Extending combination therapy with peginterferon plus ribavirin for genotype 2 chronic hepatitis C virological responders: a pilot study of 7 cases

artículo científico publicado en 2010

Factors associated with early cancer-related death after curative hepatectomy for solitary small hepatocellular carcinoma without macroscopic vascular invasion

artículo científico publicado en 2013

Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine.

artículo científico publicado en 2007

Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C.

artículo científico publicado en 2004

Favorable efficacy of daclatasvir plus asunaprevir in treatment of elderly Japanese patients infected with HCV genotype 1b aged 70 and older.

artículo científico publicado en 2016

Favorable efficacy of glecaprevir plus pibrentasvir as salvage therapy for HCV failures to prior direct-acting antivirals regimens

artículo científico publicado en 2018

Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study.

artículo científico publicado en 2005

Fibrosis score consisting of four serum markers successfully predicts pathological fibrotic stages of chronic hepatitis B

artículo científico publicado en 2012

Fulminant Hepatitis due to de novo Hepatitis B after Cord Blood Transplantation Rescued by Medical Treatment

artículo científico publicado en 2020

Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

artículo científico publicado en 2008

Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update

artículo científico publicado en 2012

HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy

artículo científico publicado en 2010

HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B.

artículo científico publicado en 2003

HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy.

artículo científico publicado en 2014

HLA-DQB1*03 confers susceptibility to chronic hepatitis C in Japanese: a genome-wide association study

artículo científico publicado en 2013

Hepatitis B virus-related hepatocellular carcinogenesis and its prevention

artículo científico publicado en 2005

Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis

artículo científico publicado en 2008

Hepatocarcinogenesis following HCV RNA eradication by interferon in chronic hepatitis patients.

artículo científico publicado en 2008

Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection

artículo científico publicado en 2004

Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan

artículo científico publicado en 2018

Hepatocellular carcinoma metastasis to the brain mimicking primary pituitary tumor around the sella turcica

artículo científico publicado en 2013

Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis

artículo científico publicado en 2005

Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation

artículo científico publicado en 2011

High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma

artículo científico publicado en 2009

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.

artículo científico publicado en 2004

Highly sensitive AFP-L3% assay is useful for predicting recurrence of hepatocellular carcinoma after curative treatment pre- and postoperatively.

artículo científico publicado en 2011

Histological improvements after a three-year lamivudine therapy in patients with chronic hepatitis B in whom YMDD mutants did not or did develop

artículo científico publicado en 2003

Impact of Mutations at Amino Acid 70 in Hepatitis C Virus (HCV) Genotype 1b Core Region on Hepatocarcinogenesis following Eradication of HCV RNA.

artículo científico publicado en 2015

Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan

artículo científico publicado en 2016

Impact of hepatitis B core-related antigen on the incidence of hepatocellular carcinoma in patients treated with nucleos(t)ide analogues

scientific article published on 20 January 2019

Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus

scientific article published on 06 February 2019

Impact of virus clearance for the development of hemorrhagic stroke in chronic hepatitis C.

artículo científico publicado en 2013

Implication of an extremely high preoperative alpha-fetoprotein value (>4,000 ng/mL) for the long-term outcomes of hepatectomy for resectable hepatocellular carcinoma.

artículo científico publicado en 2015

In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy

artículo científico publicado en 2014

Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001.

artículo científico publicado en 2004

Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.

artículo científico publicado en 2011

Influence of amino-acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b.

artículo científico publicado en 2010

Influence of hepatitis C virus subtype on hepatocellular carcinogenesis: a multivariate analysis of a retrospective cohort of 593 patients with cirrhosis

artículo científico publicado en 2002

Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus

artículo científico publicado en 2008

Initial- and re-treatment effectiveness of glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C virus-genotype 1/2/3 infections

scientific article published on 22 March 2019

Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma

artículo científico publicado en 2009

Interferon for treatment of breakthrough infection with hepatitis B virus mutants developing during long-term lamivudine therapy

artículo científico publicado en 2002

Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis.

artículo científico publicado en 2006

Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.

artículo científico publicado en 2004

Interferon therapy for 2 years or longer reduces the incidence of hepatocarcinogenesis in patients with chronic hepatitis C viral infection.

artículo científico publicado en 2004

Interferon-alpha for reinfection with hepatitis C virus in two patients with chronic hepatitis C who had responded to previous therapies

artículo científico publicado en 2003

Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.

artículo científico publicado en 2007

Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B.

artículo científico publicado en 2005

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

artículo científico publicado en 2011

Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens.

artículo científico publicado en 2017

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

artículo científico publicado en 2018

Lipiodol and dye at the site of ablation decreases during RFA.

artículo científico publicado en 2008

Liver Fibrosis and Body Mass Index Predict Hepatocarcinogenesis following Eradication of Hepatitis C Virus RNA by Direct-Acting Antivirals.

artículo científico publicado en 2016

Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma

artículo científico publicado en 2016

Long-term clinical remission induced by corticosteroid withdrawal therapy (CSWT) in patients with chronic hepatitis B infection: a prospective randomized controlled trial--CSWT with and without follow-up interferon-alpha therapy

artículo científico publicado en 2002

Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

artículo científico publicado en 2012

Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infection.

artículo científico publicado en 2015

Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine

artículo científico publicado en 2013

Long-term efficacy of interferon therapy in patients with chronic hepatitis B virus infection in Japan.

artículo científico publicado en 2012

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

artículo científico publicado en 2013

Long-term follow up of peginterferon-α-2a treatment of hepatitis B e-antigen (HBeAg) positive and HBeAg negative chronic hepatitis B patients in phase II and III studies

artículo científico publicado en 2015

Long-term follow-up of HBeAg-positive young adult Japanese patients treated with corticosteroid withdrawal therapy for chronic hepatitis B

scientific article published on 21 August 2006

Long-term follow-up of interferon monotherapy in 454 consecutive naive patients infected with hepatitis C virus: multi-course interferon therapy may reduce the risk of hepatocellular carcinoma and increase survival

artículo científico publicado en 2005

Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma

artículo científico publicado en 2012

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

artículo científico publicado en 2006

Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C.

artículo científico publicado en 2007

Long-term outcome of HBV carriers with negative HBe antigen and normal aminotransferase.

artículo científico publicado en 2006

Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan

artículo científico publicado en 2018

Long-term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus-related liver cirrhosis after interferon-based therapy

artículo científico publicado en 2019

Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance.

artículo científico publicado en 2007

Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis -- an open-cohort study

artículo científico publicado en 2003

Losartan reduces the onset of type 2 diabetes in hypertensive Japanese patients with chronic hepatitis C.

artículo científico publicado en 2009

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine

scientific article published on 01 October 2007

Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.

artículo científico publicado en 2004

Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up

artículo científico publicado en 2008

Magnetic resonance laparoscopy: A new non-invasive technique for the assessment of chronic viral liver disease

artículo científico publicado en 2013

Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiolo

scientific article published on 11 December 2019

Minimum resection margin should be based on tumor size in hepatectomy for hepatocellular carcinoma in hepatoviral infection patients

artículo científico publicado en 2013

Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease

artículo científico publicado en 2009

Mutations of polymerase, precore and core promoter gene in hepatitis B virus during 5-year lamivudine therapy

artículo científico publicado en 2002

Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapies.

artículo científico publicado en 2016

Natural histories of hepatitis C virus infection in men and women simulated by the Markov model

artículo científico publicado en 2003

Natural history of compensated cirrhosis in the Child-Pugh class A compared between 490 patients with hepatitis C and 167 with B virus infections.

artículo científico publicado en 2006

Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral load

artículo científico publicado en 2008

Necessities of interferon therapy in elderly patients with chronic hepatitis C.

artículo científico publicado en 2009

New Discriminant Method for Identifying the Aggressive Disease Phenotype of Non-alcoholic Fatty Liver Disease

artículo científico publicado en 2017

New ablation procedure for a radiofrequency liver tissue coagulation system using an expandable needle.

artículo científico publicado en 2007

New classification of dynamic computed tomography images predictive of malignant characteristics of hepatocellular carcinoma

scientific article published on 01 October 2010

New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan

artículo científico publicado en 2015

No-touch ablation in HCC has the potential to prevent intrasubsegmental recurrence to the same degree as surgical resection

artículo científico publicado en 2018

Non-invasive predictors of prognosis of Asian patients with histopathologically-confirmed lean nonalcoholic fatty liver disease

artículo científico publicado en 2020

Origin of neovascular structure in an early stage of hepatocellular carcinoma: study of alpha-smooth muscle actin immunohistochemistry in serial thin sections of surgically resected cancer

artículo científico publicado en 2006

Outcome of All-Oral Direct-Acting Antiviral Regimens on the Rate of Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Genotype 1-Related Chronic Liver Disease

artículo científico publicado en 2017

Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study

artículo científico publicado en 2014

Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis

scientific article published on 01 July 2004

Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan

artículo científico publicado en 2005

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2016

Platelet-Albumin Score as a Sensitive Measure for Surgical Risk Prediction and Survival Outcomes of Patients with Hepatocellular Carcinoma

artículo científico publicado en 2018

Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads

artículo científico publicado en 2008

Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal Liver

scientific article published on 17 October 2019

Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.

artículo científico publicado en 2017

Potential and Clinical Significance of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Evaluating Liver Cancer Response to Lenvatinib Treatment

artículo científico publicado en 2020

Potential impact of joint association of alanine aminotransferase and gamma-glutamyltransferase on insulin resistance in Japan: The Toranomon Hospital Health Management Center Study 19 (TOPICS 19).

artículo científico publicado en 2014

Potential of a no-touch pincer ablation procedure for small hepatocellular carcinoma that uses a multipolar radiofrequency ablation system: An experimental animal study

artículo científico publicado en 2014

Potential of a no-touch pincer ablation procedure that uses a multipolar radiofrequency ablation system to prevent intrasubsegmental recurrence of small and single hepatocellular carcinomas.

artículo científico publicado en 2016

Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses

artículo científico publicado en 2008

Potential of ultra-highly sensitive immunoassays for hepatitis B surface and core-related antigens in patients with or without development of hepatocellular carcinoma after hepatitis B surface antigen seroclearance

artículo científico publicado en 2020

Precore wild-type hepatitis B virus with G1896 in the resolution of persistent hepatitis B virus infection.

artículo científico publicado en 2003

Prediction model of hepatocarcinogenesis for patients with hepatitis C virus-related cirrhosis. Validation with internal and external cohorts

artículo científico publicado en 2006

Prediction of response to pegylated interferon and ribavirin in hepatitis C by polymorphisms in the viral core protein and very early dynamics of viremia.

artículo científico publicado en 2007

Prediction of treatment efficacy and telaprevir-resistant variants after triple therapy in patients infected with hepatitis C virus genotype 1.

scientific article published on 19 June 2013

Predictive factors of advanced recurrence after curative resection of small hepatocellular carcinoma

scientific article published on 27 October 2008

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

artículo científico publicado en 2006

Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.

artículo científico publicado en 2006

Predictors of Insulin Secretion in Japanese Patients with Histopathologically-confirmed Non-alcoholic Fatty Liver Disease

scientific article published on 18 September 2019

Predictors of pruritus in patients with chronic liver disease and usefulness of nalfurafine hydrochloride

artículo científico publicado en 2017

Predictors of treatment efficacy and liver stiffness changes following therapy with Sofosbuvir plus Ribavirin in patients infected with HCV genotype 2.

artículo científico publicado en 2018

Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.

artículo científico publicado en 2007

Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis

artículo científico publicado en 2020

Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL.

artículo científico publicado en 2012

Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b.

artículo científico publicado en 2012

Prevention of disease progression with anti-inflammatory therapy in patients with HCV-related cirrhosis: a Markov model.

artículo científico publicado en 2014

Previous chemoembolization response after transcatheter arterial chemoembolization (TACE) can predict the anti-tumor effect of subsequent TACE with miriplatin in patients with recurrent hepatocellular carcinoma.

artículo científico publicado en 2011

Primary liver carcinoma with sarcomatous changes: Analysis of 10 cases

artículo científico publicado en 2019

Prognosis and predictors of hepatocellular carcinoma in elderly patients infected with hepatitis B virus.

artículo científico publicado en 2017

Prolonged hepatitis after acute infection with genotype H hepatitis B virus

artículo científico publicado en 2007

Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.

artículo científico publicado en 2008

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.

artículo científico publicado en 2007

Proposed treatment guidance on new anticancer agents for the treatment of hepatocellular carcinoma, 2010 up date

article by Shuichi Kaneko et al published 2011 in Acta Hepatologica Japonica

REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

artículo científico publicado en 2019

Randomized Controlled Trial Comparing the Efficacy of Impedance Control and Temperature Control of Radiofrequency Interstitial Thermal Ablation for Treating Small Hepatocellular Carcinoma.

artículo científico publicado en 2015

Randomized controlled trial for the efficacy of hepatic arterial occlusion during radiofrequency ablation for small hepatocellular carcinoma--direct ablative effects and a long-term outcome

artículo científico publicado en 2007

Randomized controlled trial of a new procedure of radiofrequency ablation using an expandable needle for hepatocellular carcinoma

scientific article published on 02 January 2013

Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis

artículo científico publicado en 2015

Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load ⬇️

artículo científico publicado el 1 de abril de 2003

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients

artículo científico publicado en 2002

Rapid and high sensitive detection of Y93H amino acid substitution in HCV NS5A region using the PCR-Invader assay

artículo científico publicado en 2014

Rapid loss of hepatitis C virus genotype 1b from serum in patients receiving a triple treatment with telaprevir (MP-424), pegylated interferon and ribavirin for 12 weeks.

artículo científico publicado en 2009

Real-world effects of long-term rifaximin treatment for Japanese patients with hepatic encephalopathy

artículo científico publicado en 2019

Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma

artículo científico publicado en 2014

Recurrence rate and prognosis of patients with hepatocellular carcinoma that developed after elimination of hepatitis C virus RNA by interferon therapy. A closed cohort study including matched control patients

artículo científico publicado en 2003

Recurrence rates of pruritus after the stop of nalfurafine hydrochloride in chronic liver disease: Preliminary prospective confirmatory trial

artículo científico publicado en 2018

Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan

artículo científico publicado en 2015

Relationships between serum asunaprevir concentration and alanine aminotransferase elevation during daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.

artículo científico publicado en 2015

Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B

artículo científico publicado en 2013

Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C.

artículo científico publicado en 2006

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.

artículo científico publicado en 2016

Role of NS5A-L31/Y93 Double Wild-type in Failure of Glecaprevir/Pibrentasvir Double Therapy in Two Patients with a History of Direct-acting Antiviral Agent Failure: An Ultra-deep Sequencing Analysis

artículo científico publicado en 2019

SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology

scientific article published on 23 May 2020

Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study

artículo científico publicado en 2016

Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H.

artículo científico publicado en 2007

Serial changes in liver stiffness and controlled attenuation parameter following direct-acting antiviral therapy against hepatitis C virus genotype 1b.

artículo científico publicado en 2017

Seroclearance rate of hepatitis B surface antigen in 2,112 patients with chronic hepatitis in Japan during long-term follow-up.

artículo científico publicado en 2013

Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin.

artículo científico publicado en 2007

Serum levels of gamma-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection

artículo científico publicado en 2003

Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis B.

artículo científico publicado en 2004

Side effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.

artículo científico publicado en 2007

Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot study

artículo científico publicado en 2005

Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis.

artículo científico publicado en 2003

Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan

artículo científico publicado en 2015

Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C.

artículo científico publicado en 2005

Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model

artículo científico publicado en 2011

Stepwise hook extension technique for radiofrequency ablation therapy of hepatocellular carcinoma

artículo científico publicado en 2002

Strategy for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization using epirubicin

artículo científico publicado en 2010

Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma

artículo científico publicado en 2008

Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation.

artículo científico publicado en 2004

Suitable treatment period in patients with virological response during combination therapy of peginterferon and ribavirin for chronic hepatitis C.

artículo científico publicado en 2008

Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial

artículo científico publicado en 2014

Sustained negativity for HCV-RNA over 24 or more months by long-term interferon therapy correlates with eradication of HCV in patients with hepatitis C virus genotype 1b and high viral load

artículo científico publicado en 2004

Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.

artículo científico publicado en 2016

Sustained virological response in a patient with chronic hepatitis C treated by monotherapy with the NS3-4A protease inhibitor telaprevir

artículo científico publicado en 2009

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.

artículo científico publicado en 2009

TERT Promoter Mutation in Serum Cell-Free DNA Is a Diagnostic Marker of Primary Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2020

The Lack of Hepatocyte Steatosis in Adult-onset Type II Citrullinemia Patients as Assessed by 7-year Interval Paired Biopsies

artículo científico publicado en 2019

The complex association of virus- and host-related factors with HCC rate following HCV clearance

scientific article published on 02 January 2019

The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease.

artículo científico publicado en 2011

The efficacy and safety of dual oral therapy with daclatasvir and asunaprevir for genotype 1b in Japanese real-life settings

artículo científico publicado en 2017

The efficacy of 24-week interferon monotherapy for type C liver cirrhosis in Japanese patients with genotype 1b and low virus load

artículo científico publicado en 2008

The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2.

artículo científico publicado en 2009

The efficacy of short-term interferon-beta therapy for chronic hepatitis C patients with low virus load

artículo científico publicado en 2008

The efficacy of short-term interferon-beta therapy for type C cirrhotic patients with genotype 2a and low virus load.

artículo científico publicado en 2008

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.

artículo científico publicado en 2003

The influence of histological differentiation grade on the outcome of liver resection for hepatocellular carcinomas 2 cm or smaller in size

artículo científico publicado en 2015

Therapeutic effects of short- and intermediate-term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis

artículo científico publicado en 2014

Three-Dimensional Imaging Using Contrast-Enhanced and Three-Dimensional Ultrasound Techniques in the Ablative Zone Treated with a Multipolar Radiofrequency Ablation System for Hepatocellular Carcinoma.

artículo científico publicado en 2016

Three-dimensional magnetic resonance imaging for stringent diagnosis of advanced fibrosis associated with nonalcoholic steatohepatitis.

artículo científico publicado en 2013

Time-to-Interventional Failure as a New Surrogate Measure for Survival Outcomes after Resection of Hepatocellular Carcinoma

scientific article published on 12 June 2019

Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

artículo científico publicado en 2017

Transcatheter arterial chemotherapy using miriplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.

artículo científico publicado en 2011

Transcatheter arterial chemotherapy with miriplatin for hepatocellular carcinoma patients with chronic renal failure: report of three cases

artículo científico publicado en 2013

Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure

artículo científico publicado el 1 de noviembre de 2011

Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy

artículo científico publicado en 2003

Undifferentiated carcinoma of the liver demonstrated by contrast-enhanced ultrasonography

scientific article published on 10 July 2020

Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules

artículo científico publicado en 2016

Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus.

artículo científico publicado en 2003

Usefulness of the serum KL-6 assay in patients with hepatitis C virus

artículo científico publicado en 2005

Utility of detection of telaprevir-resistant variants for prediction of efficacy of treatment of hepatitis C virus genotype 1 infection

artículo científico publicado en 2013

Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers

scientific journal article

Viral dynamics and pharmacokinetics in combined interferon alfa-2b and ribavirin therapy for patients infected with hepatitis C virus of genotype 1b and high pretreatment viral load

artículo científico publicado en 2002

Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C.

artículo científico publicado en 2007

Viral genotypes and response to interferon in patients with acute prolonged hepatitis B virus infection of adulthood in Japan

artículo científico publicado en 2002

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir

artículo científico publicado en 2014

Virological and biochemical features in elderly HCV patients with hepatocellular carcinoma: amino acid substitutions in HCV core region as predictor of mortality after first treatment.

artículo científico publicado en 2009

Virological and biochemical relapse according to YMDD motif mutant type during long‐term lamivudine monotherapy ⬇️

artículo científico publicado el 1 de diciembre de 2003

Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatment

artículo científico publicado en 2005

Virological differences between patients infected with subtypes Ba and Bj of hepatitis B virus genotype B.

artículo científico publicado en 2005

Virological outcomes in patients infected chronically with hepatitis B virus genotype A in comparison with genotypes B and C.

artículo científico publicado en 2006

Virological response and hepatocarcinogenesis in lamivudine-resistant hepatitis B virus genotype C patients treated with lamivudine plus adefovir dipivoxil.

artículo científico publicado en 2008

Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus.

artículo científico publicado en 2010

What Is the Most Effective Drug Delivery System for Cisplatin during the Treatment of Hepatic Tumors with Single-Session Transcatheter Chemotherapy? A Pilot Study

artículo científico publicado en 2013

YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine

artículo científico publicado en 2004

[Case report; Fanconi's syndrome and hypophosphatemic osteomalacia associated with adefovir dipivoxil: a case report]

artículo científico publicado en 2014

[Case report; Intestinal Behçet's disease in monozygotic twins]

artículo científico publicado en 2014

[Transcatheter arterial chemoembolization with a lipophilic platinum complex SM-11355(miriplatin hydrate)--safety and efficacy in combination with embolizing agents]

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda